Maurizio Memo

Prof. Maurizio Memo

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 1996 in Science
Verified
Journal Article
Closed access
PDF file
MGMariagrazia Grilli
Mariagrazia Grilli
MPM Pizzi
M Pizzi
Maurizio MemoMaurizio Memo
Maurizio Memo
PSPierFranco Spano
PierFranco Spano
Aspirin (acetylsalicylic acid) is a commonly prescribed drug with a wide pharmacological spectrum. At concentrations compatible with amounts in plasma during chronic anti-inflammatory therapy, acetylsalicylic acid and its metabolite sodium salicylate were found to be protective against neurotoxicity elicited by the excitatory amino acid glutamate in rat primary neuronal cultures and hippocampal slices. The site of action of the drugs appeared to be downstream of glutamate receptors and to involve specific inhibition of glutamate-mediated induction of nuclear factor kappa B. These results may contribute to the emerging theme of anti-inflammatory drugs and neurodegeneration.

8 March 2012 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
ASAdriana Sánchez‐Danés
Adriana Sánchez‐Danés
YRYvonne Richaud‐Patin
Yvonne Richaud‐Patin
ICIria Carballo‐Carbajal
Iria Carballo‐Carbajal
SJSenda Jiménez‐Delgado
Senda Jiménez‐Delgado
CCCarles Caig
Carles Caig
Angel RayaAngel Raya
Angel Raya
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in relevant cell types, but it is unclear whether they could successfully model age‐related diseases such as Parkinson9s disease (PD). Here, we generated iPSC lines from seven patients with idiopathic PD (ID‐PD), four patients with familial PD associated to the G2019S mutation in the Leucine‐Rich Repeat Kinase 2 (LRRK2) gene (LRRK2‐PD) and four age‐ and sex‐matched healthy individuals (Ctrl). Over long‐time culture, dopaminergic neurons (DAn) differentiated from either ID‐PD‐ or LRRK2‐PD‐iPSC showed morphological alterations, including reduced numbers of neurites and neurite arborization, as well as accumulation of autophagic vacuoles, which were not evident in DAn differentiated from Ctrl‐iPSC. Further induction of autophagy and/or inhibition of lysosomal proteolysis greatly exacerbated the DAn morphological alterations, indicating autophagic compromise in DAn from ID‐PD‐ and LRRK2‐PD‐iPSC, which we demonstrate occurs at the level of autophagosome clearance. Our study provides an iPSC‐based in vitro model that captures the patients9 genetic complexity and allows investigation of the pathogenesis of both sporadic and familial PD cases in a disease‐relevant cell type.

26 March 2019 in Biomedicines
Verified
Journal Article
Open access
PDF file
RBRam Manohar Basnet
Ram Manohar Basnet
DZDaniela Zizioli
Daniela Zizioli
STSomrat Taweedet
Somrat Taweedet
Dario FinazziDario Finazzi
Dario Finazzi
Maurizio MemoMaurizio Memo
Maurizio Memo
Zebrafish larvae show a clear and distinct pattern of swimming in response to light and dark conditions, following the development of a swim bladder at 4 days post fertilization. This swimming behavior is increasingly employed in the screening of neuroactive drugs. The recent emergence of high-throughput techniques for the automatic tracking of zebrafish larvae has further allowed an objective and efficient way of finding subtle behavioral changes that could go unnoticed during manual observations. This review highlights the use of zebrafish larvae as a high-throughput behavioral model for the screening of neuroactive compounds. We describe, in brief, the behavior repertoire of zebrafish larvae. Then, we focus on the utilization of light-dark locomotion test in identifying and screening of neuroactive compounds.

1 January 2001 in Trends in Neurosciences
Verified
Journal Article
Closed access
ACAgata Copani
Agata Copani
MSMaria Angela Sortino
Maria Angela Sortino
Ferdinando NicolettiFerdinando Nicoletti
Ferdinando Nicoletti
VBValeria Maria Gloria BRUNO
Valeria Maria Gloria BRUNO
DUDaniela Ubertia
Daniela Ubertia
Maurizio MemoMaurizio Memo
Maurizio Memo

24 June 2009 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
MPMarzia Perluigi
Marzia Perluigi
RSRukhsana Sultana
Rukhsana Sultana
GCGiovanna Cenini
Giovanna Cenini
Fabio Di DomenicoFabio Di Domenico
Fabio Di Domenico
Maurizio MemoMaurizio Memo
Maurizio Memo
David Allan ButterfieldDavid Allan Butterfield
David Allan Butterfield

17 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Andrea MastinuAndrea Mastinu
Andrea Mastinu
AKAmit Kumar
Amit Kumar
GMGiuseppina Maccarinelli
Giuseppina Maccarinelli
SBSara Anna Bonini
Sara Anna Bonini
MPMarika PREMOLI
Marika PREMOLI
Maurizio MemoMaurizio Memo
Maurizio Memo
Zeolites are porous minerals with high absorbency and ion-exchange capacity. Their molecular structure is a dense network of AlO4 and SiO4 that generates cavities where water and other polar molecules or ions are inserted/exchanged. Even though there are several synthetic or natural occurring species of zeolites, the most widespread and studied is the naturally occurring zeolite clinoptilolite (ZC). ZC is an excellent detoxifying, antioxidant and anti-inflammatory agent. As a result, it is been used in many industrial applications ranging from environmental remediation to oral applications/supplementation in vivo in humans as food supplements or medical devices. Moreover, the modification as micronization of ZC (M-ZC) or tribomechanically activated zeolite clinoptilolite (TMAZ) or furthermore as double tribomechanically activated zeolite clinoptilolite (PMA-ZC) allows improving its benefits in preclinical and clinical models. Despite its extensive use, many underlying action mechanisms of ZC in its natural or modified forms are still unclear, especially in humans. The main aim of this review is to shed light on the geochemical aspects and therapeutic potentials of ZC with a vision of endorsing further preclinical and clinical research on zeolites, in specific on the ZC and its modified forms as a potential agent for promoting human brain health and overall well-being.